- Home
- GTLB vs RYTM Comparison
GTLB vs RYTM Comparison
Compare GTLB & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTLB
- RYTM
- Stock Information
- Founded
- GTLB 2011
- RYTM 2008
- Country
- GTLB United States
- RYTM United States
- Employees
- GTLB N/A
- RYTM N/A
- Industry
- GTLB EDP Services
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- GTLB Technology
- RYTM Health Care
- Exchange
- GTLB Nasdaq
- RYTM Nasdaq
- Market Cap
- GTLB 7.2B
- RYTM 6.4B
- IPO Year
- GTLB 2021
- RYTM 2017
- Fundamental
- Price
- GTLB $50.43
- RYTM $96.10
- Analyst Decision
- GTLB Buy
- RYTM Strong Buy
- Analyst Count
- GTLB 26
- RYTM 13
- Target Price
- GTLB $58.73
- RYTM $101.92
- AVG Volume (30 Days)
- GTLB 6.3M
- RYTM 548.5K
- Earning Date
- GTLB 09-03-2025
- RYTM 11-04-2025
- Dividend Yield
- GTLB N/A
- RYTM N/A
- EPS Growth
- GTLB N/A
- RYTM N/A
- EPS
- GTLB N/A
- RYTM N/A
- Revenue
- GTLB $857,947,000.00
- RYTM $156,287,000.00
- Revenue This Year
- GTLB $26.38
- RYTM $44.69
- Revenue Next Year
- GTLB $21.20
- RYTM $63.53
- P/E Ratio
- GTLB N/A
- RYTM N/A
- Revenue Growth
- GTLB 28.97
- RYTM 53.55
- 52 Week Low
- GTLB $37.90
- RYTM $45.91
- 52 Week High
- GTLB $74.18
- RYTM $106.52
- Technical
- Relative Strength Index (RSI)
- GTLB 62.46
- RYTM 47.05
- Support Level
- GTLB $48.99
- RYTM $94.39
- Resistance Level
- GTLB $51.30
- RYTM $102.46
- Average True Range (ATR)
- GTLB 2.03
- RYTM 3.19
- MACD
- GTLB 0.36
- RYTM -1.44
- Stochastic Oscillator
- GTLB 90.47
- RYTM 14.10
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.